Clinical Trial Update: Bevacizumab and Irinotecan to Treat Brain Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bevacizumab in combination with irinotecan for high-grade gliomas was terminated, and results were posted in July 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• Avastin (bevacizumab)
• Camptosar (irinotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: High-Grade Gliomas | Phase 2 | Status: TERMINATED | Results posted: 2012-07-06